| Year |
Citation |
Score |
| 2020 |
Topletz-Erickson AR, Lee AJ, Mayor JG, Rustia EL, Abdulrasool LI, Wise AL, Dailey B, DeChenne S, Walker LN, Alley SC, Endres CJ. Tucatinib Inhibits Renal Transporters OCT2 and MATE Without Impacting Renal Function in Healthy Subjects. Journal of Clinical Pharmacology. PMID 32989831 DOI: 10.1002/jcph.1750 |
0.329 |
|
| 2016 |
Endres CJ, Moss AM, Ishida K, Govindarajan R, Unadkat JD. The Role of the Equilibrative Nucleoside Transporter 1 on Tissue and Fetal Distribution of Ribavirin in the Mouse. Biopharmaceutics & Drug Disposition. PMID 27194214 DOI: 10.1002/Bdd.2015 |
0.753 |
|
| 2012 |
Moss AM, Endres CJ, Ruiz-Garcia A, Choi DS, Unadkat JD. Role of the equilibrative and concentrative nucleoside transporters in the intestinal absorption of the nucleoside drug, ribavirin, in wild-type and Ent1(-/-) mice. Molecular Pharmaceutics. 9: 2442-9. PMID 22812541 DOI: 10.1021/Mp200647A |
0.767 |
|
| 2010 |
Unadkat JD, Kirby BJ, Endres CJ, Zolnerciks JK. The impact and in vitro to in vivo prediction of transporter-based drug-drug interactions in humans Enzyme- and Transporter-Based Drug-Drug Interactions: Progress and Future Challenges. 517-553. DOI: 10.1007/978-1-4419-0840-7_21 |
0.632 |
|
| 2009 |
Endres CJ, Endres MG, Unadkat JD. Interplay of drug metabolism and transport: a real phenomenon or an artifact of the site of measurement? Molecular Pharmaceutics. 6: 1756-65. PMID 19886641 DOI: 10.1021/Mp9002392 |
0.664 |
|
| 2009 |
Endres CJ, Moss AM, Govindarajan R, Choi DS, Unadkat JD. The role of nucleoside transporters in the erythrocyte disposition and oral absorption of ribavirin in the wild-type and equilibrative nucleoside transporter 1-/- mice. The Journal of Pharmacology and Experimental Therapeutics. 331: 287-96. PMID 19602549 DOI: 10.1124/Jpet.109.153130 |
0.758 |
|
| 2009 |
Endres CJ, Moss AM, Ke B, Govindarajan R, Choi DS, Messing RO, Unadkat JD. The role of the equilibrative nucleoside transporter 1 (ENT1) in transport and metabolism of ribavirin by human and wild-type or Ent1-/- mouse erythrocytes. The Journal of Pharmacology and Experimental Therapeutics. 329: 387-98. PMID 19164463 DOI: 10.1124/Jpet.108.145854 |
0.598 |
|
| 2008 |
Govindarajan R, Endres CJ, Whittington D, LeCluyse E, Pastor-Anglada M, Tse CM, Unadkat JD. Expression and hepatobiliary transport characteristics of the concentrative and equilibrative nucleoside transporters in sandwich-cultured human hepatocytes. American Journal of Physiology. Gastrointestinal and Liver Physiology. 295: G570-80. PMID 18635603 DOI: 10.1152/Ajpgi.00542.2007 |
0.687 |
|
| 2006 |
Hu H, Endres CJ, Chang C, Umapathy NS, Lee EW, Fei YJ, Itagaki S, Swaan PW, Ganapathy V, Unadkat JD. Electrophysiological characterization and modeling of the structure activity relationship of the human concentrative nucleoside transporter 3 (hCNT3). Molecular Pharmacology. 69: 1542-53. PMID 16446384 DOI: 10.1124/Mol.105.018945 |
0.625 |
|
| 2006 |
Endres CJ, Hsiao P, Chung FS, Unadkat JD. The role of transporters in drug interactions. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 27: 501-17. PMID 16364611 DOI: 10.1016/J.Ejps.2005.11.002 |
0.723 |
|
| 2005 |
Endres CJ, Unadkat JD. Residues Met89 and Ser160 in the human equilibrative nucleoside transporter 1 affect its affinity for adenosine, guanosine, S6-(4-nitrobenzyl)-mercaptopurine riboside, and dipyridamole. Molecular Pharmacology. 67: 837-44. PMID 15557207 DOI: 10.1124/Mol.104.008102 |
0.626 |
|
| 2004 |
Endres CJ, Sengupta DJ, Unadkat JD. Mutation of leucine-92 selectively reduces the apparent affinity of inosine, guanosine, NBMPR [S6-(4-nitrobenzyl)-mercaptopurine riboside] and dilazep for the human equilibrative nucleoside transporter, hENT1. The Biochemical Journal. 380: 131-7. PMID 14759222 DOI: 10.1042/Bj20031880 |
0.648 |
|
| Show low-probability matches. |